Stromal changes as identified immunohistochemically by loss or dramatic increase of CD34 positive fibroblasts and detection of SMA-reactive myofibroblasts were observed mostly around ducts harboring moderately or poorly differentiated in situ carcinoma (Fig. 4A–D). Here, SMN1 is linked to cancer.